Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Michael John Lubienski has worked on the following 5 EPO patent applications which have been published in the last five years:

EP12771540

FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

IPC classification:
A61K 39/145, A61K 39/385, A61P 31/16, A61P 37/04, C07K 14/285, C07K 19/00, C12N 15/00, C12P 21/02
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11707193

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP11707192

IMMUNOGENIC COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Michael John Lubienski, GlaxoSmithKline Intellectual Property Management Limited
Status:
EXAMINATION REQUESTED
EP11757268

VACCINE AGAINST N. MENINGITIDIS

IPC classification:
A61K 39/095
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11708449

VACCINE COMPOSITION

IPC classification:
A61K 39/095, A61K 39/116, C07K 14/22
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Michael John Lubienski, GlaxoSmithKline Intellectual Property Management Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature